Cell MedX Corp (CMXC)
Stock Price: $0.2510 USD
-0.0180 (-6.69%)
Updated Jul 28, 2021 3:13 PM EDT - Market closed
| Market Cap | 14.91M |
| Revenue (ttm) | 64,056 |
| Net Income (ttm) | -752,561 |
| Shares Out | 59.39M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 28 |
| Last Price | $0.2510 |
| Previous Close | $0.2690 |
| Change ($) | -0.0180 |
| Change (%) | -6.69% |
| Day's Open | 0.2501 |
| Day's Range | 0.2142 - 0.2510 |
| Day's Volume | 84,549 |
| 52-Week Range | 0.2100 - 0.5400 |
News
There are no news available yet.
About CMXC
Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general relaxation and for the temporary relief of pain due to sore and/or aching muscles. The company was formerly known as Sports Asylum, In... [Read more...]
| Industry Diagnostics & Research | |
| Stock Exchange OTCMKTS | Ticker Symbol CMXC |